Delivery Order SPE2DB22D3010-SPE2DB23FP2AX
Award Date
5/1/23
Potential Completion Date
5/2/23
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,824.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of December 22, 2023. This contract is a delivery order and has a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award, valued at $17,907.12, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of February 9, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans...
This federal contract award, valued at $30,768.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens in 1.5 mL quantities, with a completion date of March 13, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,302.32, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which enables Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, a Delivery Order valued at $3,885.65, is for the supply of Ozempic 0.25-0.5 mg/dose pens. The award date is April 27, 2023, and the ultimate completion date is April 28, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $11,610.44 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not...
This federal contract award, valued at $20,138.10, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pen with a 3 ml volume. This is a firm fixed-price delivery order contract with a period of performance through November 2, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,348.87, is for the delivery of Ozempic (0.25-0.5 mg/dose) pens. This is a firm-fixed-price delivery order with a completion date of June 13, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $5,224.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used for the treatment of diabetes. The contract has an ultimate completion date of May 3, 2024 and is a firm fixed-price delivery order. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,160.24 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, with a period of performance ending on April 14, 2023. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...